A pilot study to evaluate the efficacy of cerrobend shielding stents in preventing adverse radiotherapeutic effects in buccal carcinoma patients
| Autor: | Himanshi Aggarwal, Karma Yangchen, Saumyendra V. Singh, Raghuwar Dayal Singh, Pradeep Kumar, Shuchi Tripathi, Kirti Srivastava, Teethraj Verma, Ramashanker Siddharth, Niraj Mishra |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
medicine.medical_treatment
Dentistry Trismus lcsh:RC254-282 Oral cancer radiation therapy stent 03 medical and health sciences 0302 clinical medicine Swallowing medicine Mucositis Alloys Humans Radiology Nuclear Medicine and imaging Adverse effect Radiation Injuries Radiotherapy business.industry Carcinoma Mouth Mucosa Stent Radiotherapy Dosage 030206 dentistry General Medicine Buccal administration medicine.disease lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens Dysphagia Radiation therapy Oncology Head and Neck Neoplasms 030220 oncology & carcinogenesis Stents medicine.symptom business |
| Zdroj: | Journal of Cancer Research and Therapeutics, Vol 12, Iss 1, Pp 314-317 (2016) |
| ISSN: | 1998-4138 |
| Popis: | Background: Radiation stents made of Lipowitz metal or cerrobend alloy are commonly used to shield uninvolved tissues from electron beams used in therapeutic radiation treatment of head and neck cancers. However, studies investigating the efficacy of cerrobend shielding stent in patients with unilateral buccal carcinoma remain rare. Purpose: To evaluate the efficacy of cerrobend shielding stents in minimizing the potential adverse effects of radiation on oral tissues in buccal carcinoma patients. Materials and Methods: Twenty.eight participants were selected for the study based on predetermined inclusion criteria, out of which four participants were lost to follow-.up. Half of the remaining participants. (N = 12) were randomly given cerrobend shielding stent and the remaining 12 formed the control group. The effects of radiotherapy were evaluated by using Radiation Therapy Oncology Group. (RTOG) 0435 Head and Neck adverse effects grading tool. All participants were evaluated for xerostomia, mucositis, dysphagia, salivary changes, dysguesia, pain, trismus and radiation caries at baseline and 1 and 3. months post.radiotherapy. Results: All adverse effects were higher in control compared to study group, with post therapy difference for pain in swallowing, salivary changes, mucositis, dysphagia, dry mouth and caries being statistically significant. Conclusions: Cerrobend alloy can be used effectively as shielding stent to reduce the adverse effects associated with external beam radiation therapy in unilateral buccal carcinoma patients. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|